macular edema; retinal edema

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Clinical manifestations

  • visual impairment
    • loss of clear vision centrally (central scotoma)
    • often the vision is distorted
    • patients will describe letters missing in the middle of a word

Differential diagnosis

Management

More general terms

More specific terms

Additional terms

References

  1. Geriatrics Review Syllabus, American Geriatrics Society, 5th edition, 2002-2004; 7th edition 2010
  2. FDA News Release: Aug. 10, 2012 FDA approves Lucentis to treat diabetic macular edema http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm315130.htm
  3. 3.0 3.1 Scott IU, VanVeldhuisen PC, Ip MS et al Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion. The SCORE2 Randomized Clinical Trial. JAMA. 2017;317(20):2072-2087 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28492910 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2626260
    Bressler NM Treatment of Macular Edema Due to Central Retinal Vein Occlusion. Another Score for Repackaged Bevacizumab. JAMA. 2017;317(20):2067-2069 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28492939 <Internet> http://jamanetwork.com/journals/jama/article-abstract/2626259